• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Tyrosinaemia - Articles and news items

FDA approves higher strength Orfadin capsule for HT-1

Industry news / 15 June 2016 / Victoria White, Digital Content Producer

The FDA has approved a higher strength 20mg capsule of Sobi’s Orfadin (nitisinone) for the treatment of Hereditary Tyrosinaemia type-1 (HT-1)…


Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +